The role of the epinephrine test in the diagnosis and management of children suspected of having congenital long QT syndrome

Pediatric Cardiology

Volumn 31, Issue 4, 2010, Pages 462-468

  Clur, Sally Ann B ^a,b   Chockalingam, Priya ^a,b,c   Filippini, Luc H ^d   Widyanti, Ari P ^a   Van Cruijsen, Marc ^c   Blom, Nico A ^a,b,e   Alders, Mariel ^f   Hofman, Nynke ^f   Wilde, Arthur A M ^b,c  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b Center for Congenital Heart Defects Amsterdam Leiden (CAHAL)   (Netherlands)

^c Heart Failure Research Center   (Netherlands)

^d JULIANA CHILDREN S HOSPITAL   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Arrhythmia; Beta blocker therapy; Catecholamines; Children; Diagnosis; Genes; Long QT syndrome

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DIAGNOSTIC TEST; EXERCISE TEST; FEMALE; GENETIC ANALYSIS; GENOTYPE; HEART VENTRICLE TACHYCARDIA; HUMAN; INFANT; LONG QT SYNDROME; MALE; PHENOTYPE; PRESCHOOL CHILD; SCHOOL CHILD; SCORING SYSTEM;

ADOLESCENT; ADRENERGIC AGONISTS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; EPINEPHRINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; LONG QT SYNDROME; MALE; PHENOTYPE; PREDICTIVE VALUE OF TESTS;

EID: 77954759432     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-009-9603-2     Document Type: Article

References (22)

1. Crotti L, Celano G, Dagradi F, Schwartz PJ (2008) Congenital long QT syndrome. Orphanet J Rare Dis 3:18.
2. Crotti L, Stramba-Badiale M, Pedrazzini M, Ferrandi C, Insolia R, Matteo PS et al (2005) Prevalence of the long QT syndrome. Circulation 112:U724.
3. Eddy CA, MacCormick JM, Chung SK, Crawford JR, Love DR, Rees MI et al (2008) Identification of large gene deletions and duplications in KCNQ1 and KCNH2 in patients with long QT syndrome. Heart Rhythm 5:1275-1281.
4. Etheridge SP, Sanatani S, Cohen MI, Albaro CA, Saarel EV, Bradley DJ (2007) Long QT syndrome in children in the era of implantable defibrillators. J Am Coll Cardiol 50:1335-1340.
5. Goldenberg I, Moss AJ (2008) Long QT syndrome. J Am Coll Cardiol 51:2291-2300.
6. Goldenberg I, Moss AJ, Peterson DR, McNitt S, Zareba W, Andrews ML et al (2008) Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation 117:2184-2191.
7. Hendriks KS, Grosfeld FJ, Wilde AA, van den Bout J, van Langen IM, van Tintelen JP et al (2005) High distress in parents whose children undergo predictive testing for long QT syndrome. Community Genet 8:103-113.
8. Hofman N, Wilde AA, Tan HL (2007) Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system? Eur Heart J 28:1399. (Pubitemid 47355987)
9. Kaufman ES, Gorodeski EZ, Dettmer MM, Dikshteyn M (2005) Use of autonomic maneuvers to probe phenotype/genotype discordance in congenital long QT syndrome. Am J Cardiol 96:1425-1430.
10. Keating M, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M (1991) Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 252:704-706.
11. Keating MT, Sanguinetti MC (2001) Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104:569-580.
12. Koopmann TT, Alders M, Jongbloed RJ, Guerrero S, Mannens MM, Wilde AA et al (2006) Long QT syndrome caused by a large duplication in the KCNH2 (HERG) gene undetectable by current polymerase chain reaction-based exon-scanning methodologies. Heart Rhythm 3:52-55.
13. Magnano AR, Talathoti N, Hallur R, Bloomfield DM, Garan H (2006) Sympathomimetic infusion and cardiac repolarization: the normative effects of epinephrine and isoproterenol in healthy subjects. J Cardiovasc Electrophysiol 17:983-989.
14. Schwartz PJ (1985) Idiopathic long QT syndrome: progress and questions. Am Heart J 109:399-411.
15. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS (1993) Diagnostic criteria for the long QT syndrome. An update. Circulation 88:782-784.
16. Shimizu W, Noda T, Takaki H, Kurita T, Nagaya N, Satomi K et al (2003) Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol 41:633-642.
17. Sugao M, Fujiki A, Sakabe M, Nishida K, Tsuneda T, Iwamoto J et al (2006) New quantitative methods for evaluation of dynamic changes in QT interval on 24-hour Holter ECG recordings: QT interval in idiopathic ventricular fibrillation and long QT syndrome. Heart 92:201-207.
18. Tester DJ, Ackerman MJ (2005) Genetic testing for cardiac channelopathies: ten questions regarding clinical considerations for heart rhythm allied professionals. Heart Rhythm 2:675-677.
19. Tester DJ, Will ML, Haglund CM, Ackerman MJ (2006) Effect of clinical phenotype on yield of long QT syndrome genetic testing. J Am Coll Cardiol 47:764-768.
20. van Langen IM, Birnie E, Alders M, Jongbloed RJ, Le Marec H, Wilde AA (2003) The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome. J Med Genet 40:141-145.
21. Vyas H, Ackerman MJ (2006) Epinephrine QT stress testing in congenital long QT syndrome. J Electrocardiol 39:S107-S113.
22. Vyas H, Hejlik J, Ackerman MJ (2006) Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response. Circulation 113:1385-1392.